Psoriatic Arthritis
395
47
69
238
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
104 trials with published results (26%)
Research Maturity
238 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.1%
20 terminated out of 395 trials
92.2%
+5.7% vs benchmark
25%
97 trials in Phase 3/4
44%
104 of 238 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 238 completed trials
Clinical Trials (395)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
HLA B Leader in Patients With Psoriatic Arthritis
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Modifying PEST for Psoriatic Arthritis Screening
The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint Disease
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Diet Interventions in Psoriatic Arthritis
Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis